A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy

The introduction of immune checkpoint inhibitors has demonstrated significant improvements in survival for subsets of cancer patients. However, they carry significant and sometimes life-threatening toxicities. Prompt prediction and monitoring of immune toxicities have the potential to maximise the b...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 12; no. 1; pp. 1087 - 12
Main Authors Li, Junrong, Wuethrich, Alain, Sina, Abu A. I., Cheng, Han-Hao, Wang, Yuling, Behren, Andreas, Mainwaring, Paul N., Trau, Matt
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 17.02.2021
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The introduction of immune checkpoint inhibitors has demonstrated significant improvements in survival for subsets of cancer patients. However, they carry significant and sometimes life-threatening toxicities. Prompt prediction and monitoring of immune toxicities have the potential to maximise the benefits of immune checkpoint therapy. Herein, we develop a digital nanopillar SERS platform that achieves real-time single cytokine counting and enables dynamic tracking of immune toxicities in cancer patients receiving immune checkpoint inhibitor treatment - broader applications are anticipated in other disease indications. By analysing four prospective cytokine biomarkers that initiate inflammatory responses, the digital nanopillar SERS assay achieves both highly specific and highly sensitive cytokine detection down to attomolar level. Significantly, we report the capability of the assay to longitudinally monitor 10 melanoma patients during immune inhibitor blockade treatment. Here, we show that elevated cytokine concentrations predict for higher risk of developing severe immune toxicities in our pilot cohort of patients. There is a clinical need to monitor immune-related toxicities of immune checkpoint blockade therapy. Here, the authors develop a digital SERS platform for multiplexed single cytokine counting to track immune-toxicities and demonstrate the ability to use pre-screening to identify patients at higher risk.
AbstractList The introduction of immune checkpoint inhibitors has demonstrated significant improvements in survival for subsets of cancer patients. However, they carry significant and sometimes life-threatening toxicities. Prompt prediction and monitoring of immune toxicities have the potential to maximise the benefits of immune checkpoint therapy. Herein, we develop a digital nanopillar SERS platform that achieves real-time single cytokine counting and enables dynamic tracking of immune toxicities in cancer patients receiving immune checkpoint inhibitor treatment - broader applications are anticipated in other disease indications. By analysing four prospective cytokine biomarkers that initiate inflammatory responses, the digital nanopillar SERS assay achieves both highly specific and highly sensitive cytokine detection down to attomolar level. Significantly, we report the capability of the assay to longitudinally monitor 10 melanoma patients during immune inhibitor blockade treatment. Here, we show that elevated cytokine concentrations predict for higher risk of developing severe immune toxicities in our pilot cohort of patients.
The introduction of immune checkpoint inhibitors has demonstrated significant improvements in survival for subsets of cancer patients. However, they carry significant and sometimes life-threatening toxicities. Prompt prediction and monitoring of immune toxicities have the potential to maximise the benefits of immune checkpoint therapy. Herein, we develop a digital nanopillar SERS platform that achieves real-time single cytokine counting and enables dynamic tracking of immune toxicities in cancer patients receiving immune checkpoint inhibitor treatment - broader applications are anticipated in other disease indications. By analysing four prospective cytokine biomarkers that initiate inflammatory responses, the digital nanopillar SERS assay achieves both highly specific and highly sensitive cytokine detection down to attomolar level. Significantly, we report the capability of the assay to longitudinally monitor 10 melanoma patients during immune inhibitor blockade treatment. Here, we show that elevated cytokine concentrations predict for higher risk of developing severe immune toxicities in our pilot cohort of patients. There is a clinical need to monitor immune-related toxicities of immune checkpoint blockade therapy. Here, the authors develop a digital SERS platform for multiplexed single cytokine counting to track immune-toxicities and demonstrate the ability to use pre-screening to identify patients at higher risk.
The introduction of immune checkpoint inhibitors has demonstrated significant improvements in survival for subsets of cancer patients. However, they carry significant and sometimes life-threatening toxicities. Prompt prediction and monitoring of immune toxicities have the potential to maximise the benefits of immune checkpoint therapy. Herein, we develop a digital nanopillar SERS platform that achieves real-time single cytokine counting and enables dynamic tracking of immune toxicities in cancer patients receiving immune checkpoint inhibitor treatment - broader applications are anticipated in other disease indications. By analysing four prospective cytokine biomarkers that initiate inflammatory responses, the digital nanopillar SERS assay achieves both highly specific and highly sensitive cytokine detection down to attomolar level. Significantly, we report the capability of the assay to longitudinally monitor 10 melanoma patients during immune inhibitor blockade treatment. Here, we show that elevated cytokine concentrations predict for higher risk of developing severe immune toxicities in our pilot cohort of patients.There is a clinical need to monitor immune-related toxicities of immune checkpoint blockade therapy. Here, the authors develop a digital SERS platform for multiplexed single cytokine counting to track immune-toxicities and demonstrate the ability to use pre-screening to identify patients at higher risk.
There is a clinical need to monitor immune-related toxicities of immune checkpoint blockade therapy. Here, the authors develop a digital SERS platform for multiplexed single cytokine counting to track immune-toxicities and demonstrate the ability to use pre-screening to identify patients at higher risk.
ArticleNumber 1087
Author Wuethrich, Alain
Cheng, Han-Hao
Mainwaring, Paul N.
Trau, Matt
Wang, Yuling
Behren, Andreas
Sina, Abu A. I.
Li, Junrong
Author_xml – sequence: 1
  givenname: Junrong
  orcidid: 0000-0002-3777-2245
  surname: Li
  fullname: Li, Junrong
  organization: Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland
– sequence: 2
  givenname: Alain
  orcidid: 0000-0001-9569-0478
  surname: Wuethrich
  fullname: Wuethrich, Alain
  email: a.wuethrich@uq.edu.au
  organization: Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland
– sequence: 3
  givenname: Abu A. I.
  orcidid: 0000-0001-8099-3863
  surname: Sina
  fullname: Sina, Abu A. I.
  organization: Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland
– sequence: 4
  givenname: Han-Hao
  orcidid: 0000-0002-4663-5111
  surname: Cheng
  fullname: Cheng, Han-Hao
  organization: Centre for Microscopy and Microanalysis, The University of Queensland
– sequence: 5
  givenname: Yuling
  orcidid: 0000-0003-3627-7397
  surname: Wang
  fullname: Wang, Yuling
  email: yuling.wang@mq.edu.au
  organization: Department of Molecular Sciences, ARC Centre of Excellence for Nanoscale BioPhotonics, Faculty of Science and Engineering, Macquarie University
– sequence: 6
  givenname: Andreas
  orcidid: 0000-0001-5329-280X
  surname: Behren
  fullname: Behren, Andreas
  organization: Oliva Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Department of Medicine, University of Melbourne
– sequence: 7
  givenname: Paul N.
  surname: Mainwaring
  fullname: Mainwaring, Paul N.
  organization: Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland
– sequence: 8
  givenname: Matt
  orcidid: 0000-0001-5516-1280
  surname: Trau
  fullname: Trau, Matt
  email: m.trau@uq.edu.au
  organization: Centre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, School of Chemistry and Molecular Biosciences, The University of Queensland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33597530$$D View this record in MEDLINE/PubMed
BookMark eNp9kVtvFSEUhYmpsbX2D_hgSHwe5TqXF5OmqdqkiYnVZ7IHmFNOGBiB09p_L6dTa_siD1w2a60N-V6jgxCDRegtJR8o4f3HLKhou4Yw2jAqOG1uX6AjRgRtaMf4wZP9ITrJeUvq4APthXiFDjmXQyc5OUL5FBu3cQU8zi5svG3m6K3eeYsDhLg47yHhq_PvV3jxUKaYZlwnvCRrnC7VgiEYPMfgSkz7o5vnXbC4xN9Ou-Jsxi6sxViubYLl7g16OYHP9uRhPUY_P5__OPvaXH77cnF2etloKUhpOt7Jdmgl5YMRQorRcDGNkko2DD2TrdDMEGHadoJhIhJAW86YBQsttVRO_BhdrLkmwlYtyc2Q7lQEp-4LMW0UpOK0twoMh1YTKkcDQmo-amGoZpPWpJOThZr1ac1aduNsjbahJPDPQp_fBHetNvFGdX0_DJTVgPcPASn-2tlc1DbuUqj_V0wMFU3Xi7aq2KrSKeac7PTYgRK1565W7qpyV_fc1W01vXv6tkfLX8pVwFdBXvaIbPrX-z-xfwCDfb33
CitedBy_id crossref_primary_10_1088_1361_6528_acd4c7
crossref_primary_10_1021_acsanm_4c01202
crossref_primary_10_3390_chemosensors11080461
crossref_primary_10_6023_A21100469
crossref_primary_10_1039_D3SD00144J
crossref_primary_10_1002_adom_202302848
crossref_primary_10_3390_cancers13122865
crossref_primary_10_1021_acsanm_2c01105
crossref_primary_10_3390_bios12121105
crossref_primary_10_1088_2050_6120_ad46e6
crossref_primary_10_1016_j_bios_2022_114709
crossref_primary_10_3389_fbioe_2021_735711
crossref_primary_10_1016_j_bios_2021_113920
crossref_primary_10_1016_j_saa_2021_120366
crossref_primary_10_1021_acs_analchem_2c02398
crossref_primary_10_1021_acs_analchem_3c01273
crossref_primary_10_1016_j_snb_2024_135804
crossref_primary_10_1107_S2052252522002901
crossref_primary_10_1007_s10853_023_08816_6
crossref_primary_10_1016_j_mtchem_2023_101698
crossref_primary_10_1016_j_snb_2023_134597
crossref_primary_10_3390_chemosensors11020110
crossref_primary_10_1016_j_snb_2023_134631
crossref_primary_10_1016_j_saa_2023_123154
crossref_primary_10_1021_acs_analchem_1c01657
crossref_primary_10_1039_D1AN01108A
crossref_primary_10_1039_D3TA02707D
crossref_primary_10_1039_D2NR03005E
crossref_primary_10_1021_acs_analchem_3c05120
crossref_primary_10_1039_D3CS01060K
crossref_primary_10_1039_D3NR00303E
crossref_primary_10_1364_OE_480898
crossref_primary_10_1021_acsanm_1c00905
crossref_primary_10_1002_adfm_202307584
crossref_primary_10_1364_JOSAB_426526
crossref_primary_10_3390_bios13010046
crossref_primary_10_1016_j_talanta_2023_124460
crossref_primary_10_1515_nanoph_2021_0620
crossref_primary_10_1364_AOP_479884
crossref_primary_10_1016_j_bios_2024_116347
crossref_primary_10_1021_acs_analchem_1c03646
crossref_primary_10_1016_j_bios_2022_114004
crossref_primary_10_1016_j_saa_2023_123786
crossref_primary_10_1016_j_ccr_2022_214711
crossref_primary_10_1021_acsphotonics_1c01934
crossref_primary_10_1002_anse_202200064
crossref_primary_10_1016_j_vacuum_2024_113320
crossref_primary_10_1016_j_microc_2024_110127
crossref_primary_10_1021_acs_analchem_2c02012
crossref_primary_10_1016_j_trac_2023_117035
crossref_primary_10_3390_antibiotics11121812
crossref_primary_10_1021_acs_analchem_3c05066
crossref_primary_10_1021_acs_nanolett_4c00289
crossref_primary_10_3390_bios12090673
crossref_primary_10_1002_advs_202204207
crossref_primary_10_1016_j_ymeth_2023_06_001
crossref_primary_10_1016_j_saa_2022_121801
crossref_primary_10_1021_acs_analchem_4c00558
crossref_primary_10_1021_acs_analchem_2c02684
crossref_primary_10_1039_D3CS01055D
crossref_primary_10_1109_JSEN_2023_3338640
crossref_primary_10_3390_chemosensors10030093
crossref_primary_10_1038_s44222_024_00208_y
crossref_primary_10_1142_S1793545821410078
crossref_primary_10_1021_jacs_2c05950
crossref_primary_10_1007_s00216_022_04395_8
crossref_primary_10_1021_acssensors_2c01552
crossref_primary_10_1038_s41565_023_01415_1
Cites_doi 10.1016/j.apsusc.2020.146269
10.1038/nrc.2016.36
10.1158/1078-0432.CCR-18-3858
10.1021/acs.analchem.9b02872
10.1186/s13229-017-0176-2
10.1021/acsnano.9b04224
10.3322/caac.21596
10.1126/science.aaa8172
10.1021/cm504251h
10.1056/NEJMra1703481
10.1038/s41551-019-0356-9
10.1038/nbt.1641
10.1038/s12276-018-0191-1
10.1016/j.cell.2015.03.030
10.2353/ajpath.2006.050479
10.3389/fimmu.2019.01265
10.1038/s41416-018-0155-1
10.1016/j.ccr.2013.02.019
10.1016/j.aca.2017.12.010
10.1002/cphc.200900119
10.1021/acssensors.8b00566
10.1016/S0140-6736(20)30183-5
10.1158/1078-0432.CCR-15-1136
10.1186/s40425-019-0582-4
10.1038/s41577-020-0275-8
10.1038/s41467-018-03725-8
10.1038/s41586-018-0023-4
10.1039/C7CS00158D
10.1021/acs.nanolett.8b01184
10.1021/acs.chemrev.5b00265
10.1038/s41584-018-0074-9
10.1039/C5AN01238D
10.1016/j.talanta.2019.05.080
10.1039/C4TC02004A
10.1038/ni.1713
10.1021/nl070157q
10.1039/C4CP05073H
10.1002/smll.201904689
10.1021/jp8101817
10.1016/j.cca.2006.06.033
10.1038/nrd2792
10.1038/nrneurol.2017.144
10.1002/smll.201000418
10.1016/S0021-9258(18)32943-0
10.1126/science.aar4060
10.1038/s41416-018-0328-y
10.1021/cr300120g
10.1021/acsami.8b10112
10.1073/pnas.1814110116
10.1124/mi.10.5.3
10.1038/s41591-018-0221-5
10.1021/jacs.8b11185
10.1158/1078-0432.CCR-18-2795
10.1002/adfm.201909306
ContentType Journal Article
Copyright The Author(s) 2021
The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2021
– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
RC3
SOI
5PM
DOA
DOI 10.1038/s41467-021-21431-w
DatabaseName SpringerOpen
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
Environment Abstracts
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
Health Research Premium Collection
Natural Science Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
Technology Collection
Technology Research Database
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
DatabaseTitleList CrossRef


Publicly Available Content Database

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer_OA刊
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 12
ExternalDocumentID oai_doaj_org_article_ad3a6c015bda45c3bc4d1c2fcc075fea
10_1038_s41467_021_21431_w
33597530
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Department of Health | National Health and Medical Research Council (NHMRC)
  grantid: APP1173669
  funderid: https://doi.org/10.13039/501100000925
– fundername: ;
  grantid: APP1173669
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADRAZ
AENEX
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LK8
M1P
M48
M7P
M~E
NAO
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AZQEC
C1K
COVID
DWQXO
FR3
GNUQQ
H94
K9.
P64
PQEST
PQUKI
PRINS
RC3
SOI
5PM
ID FETCH-LOGICAL-c540t-73756965139d4454bd34fb51529982564c2d04d66fa9f05aace322eaea61e15f3
IEDL.DBID RPM
ISSN 2041-1723
IngestDate Tue Oct 22 15:11:14 EDT 2024
Tue Sep 17 21:26:36 EDT 2024
Thu Oct 10 19:23:03 EDT 2024
Thu Nov 21 21:41:03 EST 2024
Sat Sep 28 08:24:54 EDT 2024
Fri Oct 11 20:51:34 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c540t-73756965139d4454bd34fb51529982564c2d04d66fa9f05aace322eaea61e15f3
ORCID 0000-0001-5516-1280
0000-0003-3627-7397
0000-0001-8099-3863
0000-0001-5329-280X
0000-0002-3777-2245
0000-0001-9569-0478
0000-0002-4663-5111
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889912/
PMID 33597530
PQID 2490397846
PQPubID 546298
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_ad3a6c015bda45c3bc4d1c2fcc075fea
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7889912
proquest_journals_2490397846
crossref_primary_10_1038_s41467_021_21431_w
pubmed_primary_33597530
springer_journals_10_1038_s41467_021_21431_w
PublicationCentury 2000
PublicationDate 2021-02-17
PublicationDateYYYYMMDD 2021-02-17
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-17
  day: 17
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Beenken, Mohammadi (CR18) 2009; 8
Li, Yang, Qin (CR37) 2014; 2
Pidenko (CR45) 2018; 1019
Wang (CR43) 2019; 25
Masi (CR53) 2017; 8
Li, Koo, Wang, Trau (CR35) 2019; 15
Toma (CR32) 2019; 203
Lotfi (CR20) 2019; 10
Li (CR40) 2018; 10
Liu (CR26) 2018; 18
Honjo (CR19) 2019; 7
Yelleswarapu (CR50) 2019; 116
Bono (CR15) 2013; 23
Calabrese, Calabrese, Cappelli (CR12) 2018; 14
Topalian, Taube, Anders, Pardoll (CR5) 2016; 16
Schlücker (CR47) 2009; 10
Wang, Yan, Chen (CR29) 2013; 113
Malemud (CR16) 2007; 375
Cuypers (CR33) 1983; 258
Berraondo (CR14) 2019; 120
Tsao (CR48) 2018; 9
Sharma, Allison (CR1) 2015; 161
Mir-Simon, Reche-Perez, Guerrini, Pazos-Perez, Alvarez-Puebla (CR46) 2015; 27
Yshii, Hohlfeld, Liblau (CR10) 2017; 13
Langer (CR30) 2020; 14
Wu, Milutinovic, Walt (CR51) 2015; 140
Ribas, Wolchok (CR6) 2018; 359
McLellan, Li, Siekkinen, Xia (CR49) 2007; 7
Gajos, Szafraniec, Petrou, Budkowski (CR34) 2020; 518
Sharma, Allison (CR2) 2020; 20
Sharma, Allison (CR3) 2015; 348
Zittermann, Issekutz (CR17) 2006; 168
Mickert (CR39) 2019; 91
Postow, Sidlow, Hellmann (CR7) 2018; 378
Lane, Qian, Nie (CR28) 2015; 115
Johnson, Balko (CR13) 2019; 25
Wang, Cohen, Wang, Walt (CR27) 2018; 140
Rycenga (CR36) 2009; 113
Khan (CR11) 2019; 120
Wendeln (CR42) 2018; 556
Zhang, Walkenfort, Yoon, Schlucker, Xie (CR38) 2015; 17
Zhang (CR25) 2019; 3
Lim (CR9) 2019; 25
Reguera, Langer, Jimenez de Aberasturi, Liz-Marzan (CR41) 2017; 46
Darvin, Toor, Sasidharan Nair, Elkord (CR4) 2018; 50
Jones, Beamer, Ahmed (CR21) 2010; 10
CR23
Rissin (CR24) 2010; 28
Huang (CR54) 2020; 395
Chatterjee, Gnanasammandhan, Zhang (CR44) 2010; 6
Bezbradica, Medzhitov (CR22) 2009; 10
Kennedy, Salama (CR52) 2020; 70
Granger, Porter (CR31) 2018; 3
Freeman-Keller (CR8) 2016; 22
S Schlücker (21431_CR47) 2009; 10
J Langer (21431_CR30) 2020; 14
JS Bezbradica (21431_CR22) 2009; 10
B Mir-Simon (21431_CR46) 2015; 27
P Sharma (21431_CR3) 2015; 348
SL Topalian (21431_CR5) 2016; 16
P Sharma (21431_CR2) 2020; 20
S Khan (21431_CR11) 2019; 120
P Berraondo (21431_CR14) 2019; 120
O Honjo (21431_CR19) 2019; 7
A Ribas (21431_CR6) 2018; 359
LH Calabrese (21431_CR12) 2018; 14
Y Wang (21431_CR29) 2013; 113
A Beenken (21431_CR18) 2009; 8
PA Cuypers (21431_CR33) 1983; 258
JM McLellan (21431_CR49) 2007; 7
A Masi (21431_CR53) 2017; 8
K Gajos (21431_CR34) 2020; 518
LM Yshii (21431_CR10) 2017; 13
SY Lim (21431_CR9) 2019; 25
N Lotfi (21431_CR20) 2019; 10
M Freeman-Keller (21431_CR8) 2016; 22
DM Rissin (21431_CR24) 2010; 28
A-C Wendeln (21431_CR42) 2018; 556
21431_CR23
K Toma (21431_CR32) 2019; 203
J Reguera (21431_CR41) 2017; 46
Z Wang (21431_CR43) 2019; 25
DK Chatterjee (21431_CR44) 2010; 6
J Li (21431_CR40) 2018; 10
JH Granger (21431_CR31) 2018; 3
M Rycenga (21431_CR36) 2009; 113
SC-H Tsao (21431_CR48) 2018; 9
J-M Li (21431_CR37) 2014; 2
V Yelleswarapu (21431_CR50) 2019; 116
X Wang (21431_CR27) 2018; 140
SA Pidenko (21431_CR45) 2018; 1019
J Li (21431_CR35) 2019; 15
F Bono (21431_CR15) 2013; 23
Y Zhang (21431_CR38) 2015; 17
MJ Mickert (21431_CR39) 2019; 91
LB Kennedy (21431_CR52) 2020; 70
BA Jones (21431_CR21) 2010; 10
C Huang (21431_CR54) 2020; 395
MA Postow (21431_CR7) 2018; 378
CJ Malemud (21431_CR16) 2007; 375
P Zhang (21431_CR25) 2019; 3
C Liu (21431_CR26) 2018; 18
LA Lane (21431_CR28) 2015; 115
P Darvin (21431_CR4) 2018; 50
SI Zittermann (21431_CR17) 2006; 168
D Wu (21431_CR51) 2015; 140
P Sharma (21431_CR1) 2015; 161
DB Johnson (21431_CR13) 2019; 25
References_xml – volume: 518
  start-page: 146269
  year: 2020
  ident: CR34
  article-title: Surface density dependent orientation and immunological recognition of antibody on silicon: Tof-sims and surface analysis of two covalent immobilization methods
  publication-title: Appl. Surf. Sci.
  doi: 10.1016/j.apsusc.2020.146269
  contributor:
    fullname: Budkowski
– volume: 16
  start-page: 275
  year: 2016
  end-page: 287
  ident: CR5
  article-title: Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc.2016.36
  contributor:
    fullname: Pardoll
– volume: 25
  start-page: 1452
  year: 2019
  end-page: 1454
  ident: CR13
  article-title: Biomarkers for immunotherapy toxicity: are cytokines the answer?
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-18-3858
  contributor:
    fullname: Balko
– volume: 91
  start-page: 9435
  year: 2019
  end-page: 9441
  ident: CR39
  article-title: Measurement of sub-femtomolar concentrations of prostate-specific antigen through single-molecule counting with an upconversion-linked immunosorbent assay
  publication-title: Anal. Chem.
  doi: 10.1021/acs.analchem.9b02872
  contributor:
    fullname: Mickert
– volume: 8
  start-page: 63
  year: 2017
  ident: CR53
  article-title: Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder
  publication-title: Mol. Austism
  doi: 10.1186/s13229-017-0176-2
  contributor:
    fullname: Masi
– volume: 14
  start-page: 28
  year: 2020
  end-page: 117
  ident: CR30
  article-title: Present and future of surface-enhanced raman scattering
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b04224
  contributor:
    fullname: Langer
– volume: 70
  start-page: 86
  year: 2020
  end-page: 104
  ident: CR52
  article-title: A review of cancer immunotherapy toxicity
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21596
  contributor:
    fullname: Salama
– volume: 348
  start-page: 56
  year: 2015
  end-page: 61
  ident: CR3
  article-title: The future of immune checkpoint therapy
  publication-title: Science
  doi: 10.1126/science.aaa8172
  contributor:
    fullname: Allison
– volume: 27
  start-page: 950
  year: 2015
  end-page: 958
  ident: CR46
  article-title: Universal one-pot and scalable synthesis of sers encoded nanoparticles
  publication-title: Chem. Mater.
  doi: 10.1021/cm504251h
  contributor:
    fullname: Alvarez-Puebla
– volume: 378
  start-page: 158
  year: 2018
  end-page: 168
  ident: CR7
  article-title: Immune-related adverse events associated with immune checkpoint blockade
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1703481
  contributor:
    fullname: Hellmann
– volume: 3
  start-page: 438
  year: 2019
  end-page: 451
  ident: CR25
  article-title: Ultrasensitive detection of circulating exosomes with a 3d-nanopatterned microfluidic chip
  publication-title: Nat. Biomed. Eng.
  doi: 10.1038/s41551-019-0356-9
  contributor:
    fullname: Zhang
– volume: 28
  start-page: 595
  year: 2010
  end-page: 599
  ident: CR24
  article-title: Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1641
  contributor:
    fullname: Rissin
– volume: 50
  start-page: 1
  year: 2018
  end-page: 11
  ident: CR4
  article-title: Immune checkpoint inhibitors: recent progress and potential biomarkers
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-018-0191-1
  contributor:
    fullname: Elkord
– volume: 161
  start-page: 205
  year: 2015
  end-page: 214
  ident: CR1
  article-title: Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
  publication-title: Cell
  doi: 10.1016/j.cell.2015.03.030
  contributor:
    fullname: Allison
– volume: 168
  start-page: 835
  year: 2006
  end-page: 846
  ident: CR17
  article-title: Basic fibroblast growth factor (bfgf, fgf-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression
  publication-title: Am. J. Clin. Pathol.
  doi: 10.2353/ajpath.2006.050479
  contributor:
    fullname: Issekutz
– volume: 10
  start-page: 1265
  year: 2019
  ident: CR20
  article-title: Roles of gm-csf in the pathogenesis of autoimmune diseases: an update
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01265
  contributor:
    fullname: Lotfi
– volume: 120
  start-page: 63
  year: 2019
  end-page: 68
  ident: CR11
  article-title: Immune dysregulation in cancer patients developing immune-related adverse events
  publication-title: Br. J. Cancer
  doi: 10.1038/s41416-018-0155-1
  contributor:
    fullname: Khan
– volume: 23
  start-page: 477
  year: 2013
  end-page: 488
  ident: CR15
  article-title: Inhibition of tumor angiogenesis and growth by a small-molecule multi-fgf receptor blocker with allosteric properties
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.02.019
  contributor:
    fullname: Bono
– volume: 1019
  start-page: 14
  year: 2018
  end-page: 24
  ident: CR45
  article-title: Microstructured optical fiber-based luminescent biosensing: is there any light at the end of the tunnel? - a review
  publication-title: Anal. Chim. Acta
  doi: 10.1016/j.aca.2017.12.010
  contributor:
    fullname: Pidenko
– volume: 10
  start-page: 1344
  year: 2009
  end-page: 1354
  ident: CR47
  article-title: SERS microscopy: nanoparticle probes and biomedical applications
  publication-title: ChemPhysChem
  doi: 10.1002/cphc.200900119
  contributor:
    fullname: Schlücker
– volume: 3
  start-page: 2303
  year: 2018
  end-page: 2310
  ident: CR31
  article-title: The case for human serum as a highly preferable sample matrix for detection of anthrax toxins
  publication-title: ACS Sens.
  doi: 10.1021/acssensors.8b00566
  contributor:
    fullname: Porter
– volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  ident: CR54
  article-title: Clinical features of patients infected with 2019 novel coronavirus in wuhan, china
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
  contributor:
    fullname: Huang
– volume: 22
  start-page: 886
  year: 2016
  end-page: 894
  ident: CR8
  article-title: Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-1136
  contributor:
    fullname: Freeman-Keller
– volume: 7
  start-page: 97
  year: 2019
  ident: CR19
  article-title: Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report
  publication-title: J. Immunother. Cancer
  doi: 10.1186/s40425-019-0582-4
  contributor:
    fullname: Honjo
– volume: 20
  start-page: 75
  year: 2020
  end-page: 76
  ident: CR2
  article-title: Dissecting the mechanisms of immune checkpoint therapy
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0275-8
  contributor:
    fullname: Allison
– volume: 9
  year: 2018
  ident: CR48
  article-title: Characterising the phenotypic evolution of circulating tumour cells during treatment
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-03725-8
  contributor:
    fullname: Tsao
– volume: 556
  start-page: 332
  year: 2018
  end-page: 338
  ident: CR42
  article-title: Innate immune memory in the brain shapes neurological disease hallmarks
  publication-title: Nature
  doi: 10.1038/s41586-018-0023-4
  contributor:
    fullname: Wendeln
– volume: 46
  start-page: 3866
  year: 2017
  end-page: 3885
  ident: CR41
  article-title: Anisotropic metal nanoparticles for surface enhanced raman scattering
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C7CS00158D
  contributor:
    fullname: Liz-Marzan
– volume: 18
  start-page: 4226
  year: 2018
  end-page: 4232
  ident: CR26
  article-title: Single-exosome-counting immunoassays for cancer diagnostics
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.8b01184
  contributor:
    fullname: Liu
– volume: 115
  start-page: 10489
  year: 2015
  end-page: 10529
  ident: CR28
  article-title: SERS nanoparticles in medicine: from label-free detection to spectroscopic tagging
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.5b00265
  contributor:
    fullname: Nie
– volume: 14
  start-page: 569
  year: 2018
  end-page: 579
  ident: CR12
  article-title: Rheumatic immune-related adverse events from cancer immunotherapy
  publication-title: Nat. Rev. Rheumatol.
  doi: 10.1038/s41584-018-0074-9
  contributor:
    fullname: Cappelli
– volume: 140
  start-page: 6277
  year: 2015
  end-page: 6282
  ident: CR51
  article-title: Single molecule array (simoa) assay with optimal antibody pairs for cytokine detection in human serum samples
  publication-title: Analyst
  doi: 10.1039/C5AN01238D
  contributor:
    fullname: Walt
– volume: 203
  start-page: 274
  year: 2019
  end-page: 279
  ident: CR32
  article-title: Repeated immunosensing by a dithiobis(succinimidyl propionate)-modified saw device
  publication-title: Talanta
  doi: 10.1016/j.talanta.2019.05.080
  contributor:
    fullname: Toma
– volume: 2
  start-page: 9934
  year: 2014
  end-page: 9940
  ident: CR37
  article-title: Hollow nanocubes made of ag–au alloys for SERS detection with sensitivity of 10−8 m for melamine
  publication-title: J. Mater. Chem. C
  doi: 10.1039/C4TC02004A
  contributor:
    fullname: Qin
– volume: 10
  start-page: 333
  year: 2009
  end-page: 339
  ident: CR22
  article-title: Integration of cytokine and heterologous receptor signaling pathways
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1713
  contributor:
    fullname: Medzhitov
– volume: 7
  start-page: 1013
  year: 2007
  end-page: 1017
  ident: CR49
  article-title: The sers activity of a supported ag nanocube strongly depends on its orientation relative to laser polarization
  publication-title: Nano Lett.
  doi: 10.1021/nl070157q
  contributor:
    fullname: Xia
– ident: CR23
– volume: 17
  start-page: 21120
  year: 2015
  end-page: 21126
  ident: CR38
  article-title: Gold and silver nanoparticle monomers are non-sers-active: a negative experimental study with silica-encapsulated raman-reporter-coated metal colloids
  publication-title: Phys. Chem. Chem. Phys.
  doi: 10.1039/C4CP05073H
  contributor:
    fullname: Xie
– volume: 15
  start-page: 1904689
  year: 2019
  ident: CR35
  article-title: Native microrna targets trigger self-assembly of nanozyme-patterned hollowed nanocuboids with optimal interparticle gaps for plasmonic-activated cancer detection
  publication-title: Small
  doi: 10.1002/smll.201904689
  contributor:
    fullname: Trau
– volume: 113
  start-page: 3932
  year: 2009
  end-page: 3939
  ident: CR36
  article-title: Surface-enhanced raman scattering: comparison of three different molecules on single-crystal nanocubes and nanospheres of silver
  publication-title: J. Phys. Chem. A
  doi: 10.1021/jp8101817
  contributor:
    fullname: Rycenga
– volume: 375
  start-page: 10
  year: 2007
  end-page: 19
  ident: CR16
  article-title: Growth hormone, vegf and fgf: Involvement in rheumatoid arthritis
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2006.06.033
  contributor:
    fullname: Malemud
– volume: 8
  start-page: 235
  year: 2009
  end-page: 253
  ident: CR18
  article-title: The fgf family: biology, pathophysiology and therapy
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2792
  contributor:
    fullname: Mohammadi
– volume: 13
  start-page: 755
  year: 2017
  end-page: 763
  ident: CR10
  article-title: Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives
  publication-title: Nat. Rev. Neurol.
  doi: 10.1038/nrneurol.2017.144
  contributor:
    fullname: Liblau
– volume: 6
  start-page: 2781
  year: 2010
  end-page: 2795
  ident: CR44
  article-title: Small upconverting fluorescent nanoparticles for biomedical applications
  publication-title: Small
  doi: 10.1002/smll.201000418
  contributor:
    fullname: Zhang
– volume: 258
  start-page: 2426
  year: 1983
  end-page: 2431
  ident: CR33
  article-title: The adsorption of prothrombin to phosphatidylserine multilayers quantitated by ellipsometry
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)32943-0
  contributor:
    fullname: Cuypers
– volume: 359
  start-page: 1350
  year: 2018
  end-page: 1355
  ident: CR6
  article-title: Cancer immunotherapy using checkpoint blockade
  publication-title: Science
  doi: 10.1126/science.aar4060
  contributor:
    fullname: Wolchok
– volume: 120
  start-page: 6
  year: 2019
  end-page: 15
  ident: CR14
  article-title: Cytokines in clinical cancer immunotherapy
  publication-title: Br. J. Cancer
  doi: 10.1038/s41416-018-0328-y
  contributor:
    fullname: Berraondo
– volume: 113
  start-page: 1391
  year: 2013
  end-page: 1428
  ident: CR29
  article-title: Sers tags: novel optical nanoprobes for bioanalysis
  publication-title: Chem. Rev.
  doi: 10.1021/cr300120g
  contributor:
    fullname: Chen
– volume: 10
  start-page: 32526
  year: 2018
  end-page: 32535
  ident: CR40
  article-title: Facile one-pot synthesis of nanodot-decorated gold–silver alloy nanoboxes for single-particle surface-enhanced raman scattering activity
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.8b10112
  contributor:
    fullname: Li
– volume: 116
  start-page: 4489
  year: 2019
  end-page: 4495
  ident: CR50
  article-title: Mobile platform for rapid sub–picogram-per-milliliter, multiplexed, digital droplet detection of proteins
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1814110116
  contributor:
    fullname: Yelleswarapu
– volume: 10
  start-page: 263
  year: 2010
  end-page: 270
  ident: CR21
  article-title: Fractalkine/cx3cl1: a potential new target for inflammatory diseases
  publication-title: Mol. Interv.
  doi: 10.1124/mi.10.5.3
  contributor:
    fullname: Ahmed
– volume: 25
  start-page: 141
  year: 2019
  end-page: 151
  ident: CR43
  article-title: Paradoxical effects of obesity on t cell function during tumor progression and pd-1 checkpoint blockade
  publication-title: Nat. Med.
  doi: 10.1038/s41591-018-0221-5
  contributor:
    fullname: Wang
– volume: 140
  start-page: 18132
  year: 2018
  end-page: 18139
  ident: CR27
  article-title: Competitive immunoassays for the detection of small molecules using single molecule arrays
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.8b11185
  contributor:
    fullname: Walt
– volume: 25
  start-page: 1557
  year: 2019
  end-page: 1563
  ident: CR9
  article-title: Circulating cytokines predict immune-related toxicity in melanoma patients receiving anti-pd-1-based immunotherapy
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-18-2795
  contributor:
    fullname: Lim
– volume: 10
  start-page: 263
  year: 2010
  ident: 21431_CR21
  publication-title: Mol. Interv.
  doi: 10.1124/mi.10.5.3
  contributor:
    fullname: BA Jones
– volume: 10
  start-page: 1344
  year: 2009
  ident: 21431_CR47
  publication-title: ChemPhysChem
  doi: 10.1002/cphc.200900119
  contributor:
    fullname: S Schlücker
– volume: 378
  start-page: 158
  year: 2018
  ident: 21431_CR7
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra1703481
  contributor:
    fullname: MA Postow
– volume: 28
  start-page: 595
  year: 2010
  ident: 21431_CR24
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1641
  contributor:
    fullname: DM Rissin
– volume: 10
  start-page: 333
  year: 2009
  ident: 21431_CR22
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.1713
  contributor:
    fullname: JS Bezbradica
– volume: 3
  start-page: 2303
  year: 2018
  ident: 21431_CR31
  publication-title: ACS Sens.
  doi: 10.1021/acssensors.8b00566
  contributor:
    fullname: JH Granger
– volume: 113
  start-page: 3932
  year: 2009
  ident: 21431_CR36
  publication-title: J. Phys. Chem. A
  doi: 10.1021/jp8101817
  contributor:
    fullname: M Rycenga
– volume: 7
  start-page: 1013
  year: 2007
  ident: 21431_CR49
  publication-title: Nano Lett.
  doi: 10.1021/nl070157q
  contributor:
    fullname: JM McLellan
– volume: 6
  start-page: 2781
  year: 2010
  ident: 21431_CR44
  publication-title: Small
  doi: 10.1002/smll.201000418
  contributor:
    fullname: DK Chatterjee
– volume: 116
  start-page: 4489
  year: 2019
  ident: 21431_CR50
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1814110116
  contributor:
    fullname: V Yelleswarapu
– volume: 9
  year: 2018
  ident: 21431_CR48
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-018-03725-8
  contributor:
    fullname: SC-H Tsao
– volume: 27
  start-page: 950
  year: 2015
  ident: 21431_CR46
  publication-title: Chem. Mater.
  doi: 10.1021/cm504251h
  contributor:
    fullname: B Mir-Simon
– volume: 161
  start-page: 205
  year: 2015
  ident: 21431_CR1
  publication-title: Cell
  doi: 10.1016/j.cell.2015.03.030
  contributor:
    fullname: P Sharma
– volume: 14
  start-page: 28
  year: 2020
  ident: 21431_CR30
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b04224
  contributor:
    fullname: J Langer
– volume: 20
  start-page: 75
  year: 2020
  ident: 21431_CR2
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0275-8
  contributor:
    fullname: P Sharma
– volume: 14
  start-page: 569
  year: 2018
  ident: 21431_CR12
  publication-title: Nat. Rev. Rheumatol.
  doi: 10.1038/s41584-018-0074-9
  contributor:
    fullname: LH Calabrese
– volume: 10
  start-page: 32526
  year: 2018
  ident: 21431_CR40
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.8b10112
  contributor:
    fullname: J Li
– ident: 21431_CR23
  doi: 10.1002/adfm.201909306
– volume: 113
  start-page: 1391
  year: 2013
  ident: 21431_CR29
  publication-title: Chem. Rev.
  doi: 10.1021/cr300120g
  contributor:
    fullname: Y Wang
– volume: 359
  start-page: 1350
  year: 2018
  ident: 21431_CR6
  publication-title: Science
  doi: 10.1126/science.aar4060
  contributor:
    fullname: A Ribas
– volume: 22
  start-page: 886
  year: 2016
  ident: 21431_CR8
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-1136
  contributor:
    fullname: M Freeman-Keller
– volume: 25
  start-page: 141
  year: 2019
  ident: 21431_CR43
  publication-title: Nat. Med.
  doi: 10.1038/s41591-018-0221-5
  contributor:
    fullname: Z Wang
– volume: 16
  start-page: 275
  year: 2016
  ident: 21431_CR5
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc.2016.36
  contributor:
    fullname: SL Topalian
– volume: 18
  start-page: 4226
  year: 2018
  ident: 21431_CR26
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.8b01184
  contributor:
    fullname: C Liu
– volume: 518
  start-page: 146269
  year: 2020
  ident: 21431_CR34
  publication-title: Appl. Surf. Sci.
  doi: 10.1016/j.apsusc.2020.146269
  contributor:
    fullname: K Gajos
– volume: 120
  start-page: 63
  year: 2019
  ident: 21431_CR11
  publication-title: Br. J. Cancer
  doi: 10.1038/s41416-018-0155-1
  contributor:
    fullname: S Khan
– volume: 1019
  start-page: 14
  year: 2018
  ident: 21431_CR45
  publication-title: Anal. Chim. Acta
  doi: 10.1016/j.aca.2017.12.010
  contributor:
    fullname: SA Pidenko
– volume: 395
  start-page: 497
  year: 2020
  ident: 21431_CR54
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
  contributor:
    fullname: C Huang
– volume: 258
  start-page: 2426
  year: 1983
  ident: 21431_CR33
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)32943-0
  contributor:
    fullname: PA Cuypers
– volume: 25
  start-page: 1452
  year: 2019
  ident: 21431_CR13
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-18-3858
  contributor:
    fullname: DB Johnson
– volume: 375
  start-page: 10
  year: 2007
  ident: 21431_CR16
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2006.06.033
  contributor:
    fullname: CJ Malemud
– volume: 17
  start-page: 21120
  year: 2015
  ident: 21431_CR38
  publication-title: Phys. Chem. Chem. Phys.
  doi: 10.1039/C4CP05073H
  contributor:
    fullname: Y Zhang
– volume: 91
  start-page: 9435
  year: 2019
  ident: 21431_CR39
  publication-title: Anal. Chem.
  doi: 10.1021/acs.analchem.9b02872
  contributor:
    fullname: MJ Mickert
– volume: 115
  start-page: 10489
  year: 2015
  ident: 21431_CR28
  publication-title: Chem. Rev.
  doi: 10.1021/acs.chemrev.5b00265
  contributor:
    fullname: LA Lane
– volume: 8
  start-page: 235
  year: 2009
  ident: 21431_CR18
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2792
  contributor:
    fullname: A Beenken
– volume: 10
  start-page: 1265
  year: 2019
  ident: 21431_CR20
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.01265
  contributor:
    fullname: N Lotfi
– volume: 13
  start-page: 755
  year: 2017
  ident: 21431_CR10
  publication-title: Nat. Rev. Neurol.
  doi: 10.1038/nrneurol.2017.144
  contributor:
    fullname: LM Yshii
– volume: 348
  start-page: 56
  year: 2015
  ident: 21431_CR3
  publication-title: Science
  doi: 10.1126/science.aaa8172
  contributor:
    fullname: P Sharma
– volume: 7
  start-page: 97
  year: 2019
  ident: 21431_CR19
  publication-title: J. Immunother. Cancer
  doi: 10.1186/s40425-019-0582-4
  contributor:
    fullname: O Honjo
– volume: 3
  start-page: 438
  year: 2019
  ident: 21431_CR25
  publication-title: Nat. Biomed. Eng.
  doi: 10.1038/s41551-019-0356-9
  contributor:
    fullname: P Zhang
– volume: 23
  start-page: 477
  year: 2013
  ident: 21431_CR15
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.02.019
  contributor:
    fullname: F Bono
– volume: 140
  start-page: 18132
  year: 2018
  ident: 21431_CR27
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.8b11185
  contributor:
    fullname: X Wang
– volume: 25
  start-page: 1557
  year: 2019
  ident: 21431_CR9
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-18-2795
  contributor:
    fullname: SY Lim
– volume: 120
  start-page: 6
  year: 2019
  ident: 21431_CR14
  publication-title: Br. J. Cancer
  doi: 10.1038/s41416-018-0328-y
  contributor:
    fullname: P Berraondo
– volume: 50
  start-page: 1
  year: 2018
  ident: 21431_CR4
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-018-0191-1
  contributor:
    fullname: P Darvin
– volume: 8
  start-page: 63
  year: 2017
  ident: 21431_CR53
  publication-title: Mol. Austism
  doi: 10.1186/s13229-017-0176-2
  contributor:
    fullname: A Masi
– volume: 556
  start-page: 332
  year: 2018
  ident: 21431_CR42
  publication-title: Nature
  doi: 10.1038/s41586-018-0023-4
  contributor:
    fullname: A-C Wendeln
– volume: 203
  start-page: 274
  year: 2019
  ident: 21431_CR32
  publication-title: Talanta
  doi: 10.1016/j.talanta.2019.05.080
  contributor:
    fullname: K Toma
– volume: 46
  start-page: 3866
  year: 2017
  ident: 21431_CR41
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C7CS00158D
  contributor:
    fullname: J Reguera
– volume: 15
  start-page: 1904689
  year: 2019
  ident: 21431_CR35
  publication-title: Small
  doi: 10.1002/smll.201904689
  contributor:
    fullname: J Li
– volume: 140
  start-page: 6277
  year: 2015
  ident: 21431_CR51
  publication-title: Analyst
  doi: 10.1039/C5AN01238D
  contributor:
    fullname: D Wu
– volume: 2
  start-page: 9934
  year: 2014
  ident: 21431_CR37
  publication-title: J. Mater. Chem. C
  doi: 10.1039/C4TC02004A
  contributor:
    fullname: J-M Li
– volume: 70
  start-page: 86
  year: 2020
  ident: 21431_CR52
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21596
  contributor:
    fullname: LB Kennedy
– volume: 168
  start-page: 835
  year: 2006
  ident: 21431_CR17
  publication-title: Am. J. Clin. Pathol.
  doi: 10.2353/ajpath.2006.050479
  contributor:
    fullname: SI Zittermann
SSID ssj0000391844
Score 2.637135
Snippet The introduction of immune checkpoint inhibitors has demonstrated significant improvements in survival for subsets of cancer patients. However, they carry...
There is a clinical need to monitor immune-related toxicities of immune checkpoint blockade therapy. Here, the authors develop a digital SERS platform for...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1087
SubjectTerms 140/133
631/61/350
639/301/357/537
639/301/930/527/1821
692/699/67/1059/2325
9/10
Biomarkers
Cancer
Chemokine CX3CL1 - immunology
Chemokine CX3CL1 - metabolism
Cohort Studies
Cytokines
Cytokines - immunology
Cytokines - metabolism
Granulocyte Colony-Stimulating Factor - immunology
Granulocyte Colony-Stimulating Factor - metabolism
Granulocyte-Macrophage Colony-Stimulating Factor - immunology
Granulocyte-Macrophage Colony-Stimulating Factor - metabolism
Health services
Humanities and Social Sciences
Humans
Immune checkpoint inhibitors
Immune Checkpoint Inhibitors - adverse effects
Immune Checkpoint Inhibitors - immunology
Immune Checkpoint Inhibitors - therapeutic use
Immunotherapy
Immunotherapy - methods
Inflammation
Inhibitors
Ipilimumab - adverse effects
Ipilimumab - immunology
Ipilimumab - therapeutic use
Melanoma
Melanoma - immunology
Melanoma - metabolism
Melanoma - therapy
Microscopy, Confocal - methods
Monitoring
Monitoring, Immunologic - methods
multidisciplinary
Patients
Pilot Projects
Reproducibility of Results
Science
Science (multidisciplinary)
Spectrum Analysis, Raman - methods
Telemedicine
Toxicity
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiPIMFOQDN4jq2GMnORbUqkKCA6VSb5afEKnNrnaDSv99x3a2dHmIC5ccHEt-zNjzjedFyGubTEOs8zXzwGtoQdWdi13tZHBRWNH2Pr13fPykjk_hw5k8u1XqK_mElfTAZeP2jRdGORRa1huQTlgHvnE8OofCLoYCjRi_pUzlO1j0qLrAHCXDRLe_hnwnJI8EjhihqS-3JFFO2P8nlPm7s-QvFtMsiI4ekPszgqQHZea75E4YH5K7pabk1SOyPqB--JpKgdD0DHAe6otSATfQ0YyLZaoytKInh59P6PLcTAmzUvzQ5SqZbJITNDWjpxf5rKcZ0CGFkAQ6LX4MLudfpcNYGuforavH5PTo8Mv743qurIA0ADbVrWil6pVE-OcBJFgvIFqENiicUGVU4Lhn4JWKpo9MGuMCHvxgglFNaGQUT8jOuBjDM0JtwE7cMMeMAc5dpywEBRYVMWgi9BV5s9llvSwJNHQ2fItOF5popInONNGXFXmXCHHTMyW_zg3IEnpmCf0vlqjI3oaMej6Ra41qJjJFi3CrIk8LRW9GEUKm-GJWkXaL1lvT2P4zDt9yLu62Q4W14RV5u-GKn0P-fZnP_8cyX5B7PLFzqk7T7pGdafU9vESENNlX-TBcA1R8EWo
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Jb9QwFLagCIlLxU5KQT5wg6iO_eJ4TqitOlRIcKBU6s3ylhKpTcJMqrb_Hj8nM9WwXXJwLNnJZ_t9fish7yyahpjyOfPAc6hA5srVKndlcLWwopp51Hd8-SqPT-HzWXk2KdyWk1vl6kxMB7XvHOrI9-I1gUXZGcXlx_5njlWj0Lo6ldC4Tx4UvJLo0qfmn9Y6Fsx-rgCmWBkm1N4S0smAfgk8MoUiv96QRylt_9-45p8uk7_ZTZM4mj8m2xOPpPsj8E_IvdA-JQ_HypK3z8hyn_rmHAuCUFQGXIT8cqyDG2hr2q7HWkMLenL07YT2F2ZA5krjg_YLNNygKzQ1raeXacfjDGiDgSSBDt1N41IWVtq0Y-MUw3X7nJzOj74fHudTfYWIBLAhr0RVypksIwn0ACVYL6C2keBEERUvjhIc9wy8lLWZ1aw0xoW4_YMJRhahKGvxgmy1XRteEWpD7MQNc8wY4NwpaSFIsPE6BkUNs4y8X_1l3Y9pNHQyfwulR0x0xEQnTPR1Rg4QiHVPTIGdGrrFuZ52lDZeGOkim7HeQOmEdeALx2vnIguqg8nI7gpGPe3Lpb5bRRl5OSK6HkWIEqOMWUaqDaw3prH5pm1-pIzclYrX1oJn5MNqVdwN-e_P3Pn_DF-TRxwXKlafqXbJ1rC4Cm8iAxrs27TMfwEwlgbl
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwEB6VIlAviDeBgnzgBoHEnjjJAaGCWlVI5UBZqbfIr7SRttklG9Tuv2fsJEUL20sUOY7ieMaebzwvgLfam4aSwsaJRR5jjjIuTF3EJnOmFlrkpfXnHSff5fEMv51lZzswlTsaJ3C1VbXz9aRm3fzD9a_1Z1rwn4aQ8eLjCsNy984GnMR_Gl_dgbucbryL18kI98POLEpSaHCMndn-6h7cFyLz4abJhqgKGf23wdD_vSn_MakGSXX0EB6MEJMdDDzxCHZc-xjuDUUn109gdcBsc-5rhTB_TjB38eVQItexVrWLpS9D1LHTwx-nbDlXvQe1jC5s2XmbjveSZqq17DJsBn4ErPExJo71i-vGhAStrGmHxjG8a_0UZkeHP78ex2PpBSISJn2cizyTpcwIH1rEDLUVWGvCPiS9SKeUaLhN0EpZq7JOMqWMo53BKadk6tKsFs9gt1207gUw7agTV4lJlELOTSE1OomaNDVMaywjeDfNcrUcMmxUwTIuimogT0XkqQJ5qqsIvnhC3PT02bFDw6I7r8bFVikrlDQEdLRVmBmhDdrU8NoYAki1UxHsT2SsJo6rSA8l_sgJj0XwfKDozVcmjogg36D1xjA2n7TNRUjWnRek0aY8gvcTV_z95O2_-fLWIbyCPe7Z1dekyfdht-9-u9eEi3r9JjD7HzGmChM
  priority: 102
  providerName: Scholars Portal
– databaseName: SpringerOpen
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagCIlLRXmmtMgHbhCRxBM7eyyrVhUSHCiVerP8hEhtdrUb1Pbfd8bJLgqUA5ccEkd2_M1ovsl4Zhh7Zyk0VDQ-LzxUOSiQeeNik7s6uCisUDNP_zu-fJWn5_D5or4Yy-RQLswkfi-aj2tIqkwHCSo07WV-_ZA9QhusSJrncr79n0KVzhuAMS_m_lcntieV6L-PV_59PPKPGGkyPSdP2e7IGfnRAPIeexC6Z-zx0EXy9jlbH3Hf_qDmH5wc_8uQXw09bwPvTLdYUl-hFT87_nbGl5emJ5bK8cKXKwrS0LFnbjrPr5J20wp4S0kjgfeLm9aliqu87YabY77W7Qt2fnL8fX6aj70UcNeh6HMlVC1nskbC5wFqsF5AtLiRaI7QSZTgKl-AlzKaWSxqY1xAVQ8mGFmGso7iJdvpFl14zbgNOKgyhSuMgapyjbQQJFh0vaCMMMvY-80u6-VQMkOnULdo9ICJRkx0wkRfZ-wTAbEdSeWu0w2UAj1qjzZeGOmQuVhvoHbCOvClq6JzyHhiMBk72MCoRx1ca3QsUSgUEqyMvRoQ3c4iRE0ZxUXG1ATryTKmT7r2Z6q-rRp0UcsqYx82UvF7yn9_5v7_DX_DnlQkuNR5Rh2wnX71Kxwi--nt2yT2d6hCACY
  priority: 102
  providerName: Springer Nature
Title A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy
URI https://link.springer.com/article/10.1038/s41467-021-21431-w
https://www.ncbi.nlm.nih.gov/pubmed/33597530
https://www.proquest.com/docview/2490397846
https://pubmed.ncbi.nlm.nih.gov/PMC7889912
https://doaj.org/article/ad3a6c015bda45c3bc4d1c2fcc075fea
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFH_ahkC7ID5HYFQ-cIOsSew46bErLaNSx7Qy1Fvkr4xIbRq1QWP_Pc9OMigfFy6O4liyk_de_Ht-XwBvpDUNBan2A80inyWM-6nKU1_FRuVU0mSg7XnH7JyfXbHpIl7sQdzFwjinfSWLk3K5OimLr863slqpfucn1r-YjVBtQ1gT9fdhH7ffX1R09_ulA9RaWBsgE9C0v2Xud2CdESKEB6F_cwgPKI1tTGmwsx-5tP1_w5p_ukz-Zjd129HkETxscSQZNut9DHumfAL3m8qSt09hOyS6uLYFQYg9DFgaf9XUwTWkFOW6srWGNmQ-vpyTailqi1wJNqTaWMONdYUmotRk5STeroAUNpDEkHr9vVAuCyspyqazjeG6fQZXk_Hn0Znf1ldASrCg9hOaxHzAYwSBmrGYSU1ZLhHg4BaFiiNnKtIB05znYpAHsRDKoPgbYQQPTRjn9DkclOvSvAAiDQ6KRKACIVgUqZRLZjiTqI6xMGcDD952XzmrmjQamTN_0zRryJMheTJHnuzGg1NLiLuRNgW261hvrrOWETKhqeAK0YzUgsWKSsV0qKJcKURBuREeHHdkzFq53GaobCJ_JAi6PDhqKHo3S8cRHiQ7tN5Zxu4TZFCXkbtlSA_edVzxc8p_v-bL_57oFRxGlp1tYZrkGA7qzTfzGsFRLXsoEosE23TyoQf3hsPpfIrX0_H5xSX2jvgI70afvnx833PHD9jOWNpzIvQDRa8ZHA
link.rule.ids 230,314,727,780,784,864,885,2102,12056,12765,21388,24318,27924,27925,31719,33373,33744,38516,41120,42189,43310,43600,43805,43895,51576,53791,53793,73745,74035,74302,74412
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKwQXxJtAAR-4QdQkHjvZE2rRVgu0K9SH1JvlV8pKbRJ2g0r_PR7Hu9XyuuTgWLKTbzzzecaeIeStxtBQVtk0s1CkUIJIK1NXqeHO1EyzcmzR33E4E9NT-HzGz6LDbRmPVa50YlDUtjXoI9_x24TM205vLj9031OsGoXR1VhC4zbZwszpfES29iazr0drLwvmP68A4m2ZjFU7Swi6AU8mFJ4r5OnVhkUKifv_xjb_PDT5W-Q0GKT9B-R-ZJJ0d4D-IbnlmkfkzlBb8voxWe5SOz_HkiAU3QEXLr0cKuE62qim7bDa0IIeT46OaXeheuSu1D9ot8DQDR6Gpqqx9DKseZwBneNVEkf79ufchDysdN4MjfEW1_UTcro_Ofk4TWOFBY8FZH1aspKLseCeBloADtoyqLWnON5I-a2jAFPYDKwQtRrXGVfKOK8AnHJK5C7nNXtKRk3buOeEauc7FSozmVJQFKYSGpwA7TdkkNcwTsi71V-W3ZBIQ4YAOKvkgIn0mMiAibxKyB4Cse6JSbBDQ7s4l3FNSWWZEsbzGW0VcMO0AZubojbG86DaqYRsr2CUcWUu5Y0cJeTZgOh6FMY43jPOElJuYL0xjc03zfxbyMldVn7jmhcJeb-Sipsh__2ZL_4_wzfk7vTk8EAefJp9eUnuFSi0WIum3CajfvHDvfJ8qNevo9D_AhZACzY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgK1AviGcJFPCBG0Tr2BMne0It7Kq8VlVLpd4sx48SqU3S3aDSf4_teLdaXpccHEt2MuOZz_NE6HXlXUOk1CnRQFMogKelsmWqcqMsq1gx0d7e8XXOD07g02l-GuOfljGsciUTg6DWrfI28rG7JhCnO526HNsYFnH4Yfauu0x9BynvaY3tNG6jLacVCR2hrf3p_PBobXHxtdBLgJg5Q1g5XkKQEz5KgTrckKVXG9opFPH_G_L8M4DyNy9qUE6z--heRJV4b2CDB-iWaR6iO0OfyetHaLmHdX3m24Ngbxo4N-nF0BXX4EY2bec7Dy3w8fToGHfnsvc4FrsH7hbejeMDo7FsNL4I59_vANc-rcTgvv1Zq1CTFdfNMBgzuq4fo5PZ9Nv7gzR2W3B0AdKnBStyPuG5g4QaIIdKM7CVgztOYblrJAdFNQHNuZUTS3IplXHCwEgjeWay3LInaNS0jXmKcGXcJCqJIlICparkFRgOlbucQWZhkqA3q78suqGohgjOcFaKgSbC0UQEmoirBO17Qqxn-oLYYaBdnIl4voTUTHLlsE2lJeSKVQp0pqhVymEia2SCdldkFPGULsUNTyVoZ6DoehXGcp9zTBJUbNB6Yxubb5r6e6jPXZTuEpvRBL1dccXNkv_-zGf_3-ErdNfxu_jycf75Odqmnmd9W5piF436xQ_zwkGjvnoZef4XccgPYw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+digital+single-molecule+nanopillar+SERS+platform+for+predicting+and+monitoring+immune+toxicities+in+immunotherapy&rft.jtitle=Nature+communications&rft.au=Li%2C+Junrong&rft.au=Wuethrich%2C+Alain&rft.au=Sina%2C+Abu+A+I&rft.au=Cheng%2C+Han-Hao&rft.date=2021-02-17&rft.eissn=2041-1723&rft.volume=12&rft.issue=1&rft.spage=1087&rft_id=info:doi/10.1038%2Fs41467-021-21431-w&rft_id=info%3Apmid%2F33597530&rft.externalDocID=33597530
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon